期刊
FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.684162
关键词
pharmacogenomic; NSAID (non-steroidal anti-inflammatory drug); gastrointestinal toxicities; aspirin; adverse drug reaction
资金
- Medical Research Council grant for the Center for Drug Safety Science, University of Liverpool [MR/L006758/1]
- MRC [MR/L006758/1, MR/S000933/1] Funding Source: UKRI
NSAIDs are commonly used drugs for pain and inflammation, but chronic use can lead to serious gastrointestinal adverse reactions. Some clinical and genetic predisposing factors have been identified, but further research is needed to determine relevant genetic and non-genetic markers for NSAID-induced peptic ulceration.
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of drugs which are widely used globally for the treatment of pain and inflammation, and in the case of aspirin, for secondary prevention of cardiovascular disease. Chronic non-steroidal anti-inflammatory drug use is associated with potentially serious upper gastrointestinal adverse drug reactions (ADRs) including peptic ulcer disease and gastrointestinal bleeding. A few clinical and genetic predisposing factors have been identified; however, genetic data are contradictory. Further research is needed to identify clinically relevant genetic and non-genetic markers predisposing to NSAID-induced peptic ulceration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据